This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Dentognostics Gmbh, Oy Medix Biochemica Ab. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Solingen, DE (2019)
- Sollingen, DE (2022)
Company Filing History:
2 out of 2 
2 out of 12 Years Active: 2019-2022
Title: Dirk-Rolf Gieselmann: Innovator in MMP-8 Activation Products
Introduction
Dirk-Rolf Gieselmann is a notable inventor based in Solingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of MMP-8 activation products. With a total of 2 patents, Gieselmann's work has implications for diagnosing diseases related to abnormal levels of activated MMP-8.
Latest Patents
Gieselmann's latest patents include innovative methods for detecting MMP-8 activation products. One of his inventions focuses on a novel MMP-8 activation product, specifically a MMP-8 middle-part activation product. This invention relates to the detection of such products or activated MMP-8 fragments in biological samples. The methods developed can be used for diagnosing diseases associated with elevated levels of activated MMP-8. Another patent also addresses MMP-8 activation products, detailing their size and methods for detection in biological samples.
Career Highlights
Throughout his career, Gieselmann has worked with various companies, including Medix Biochemica and Dentognostics. His expertise in biochemistry has allowed him to contribute to advancements in medical diagnostics and treatment.
Collaborations
Gieselmann has collaborated with notable professionals in his field, including Kurt Maier and Timo Arto Sorsa. These collaborations have further enriched his research and development efforts.
Conclusion
Dirk-Rolf Gieselmann's contributions to the field of MMP-8 activation products highlight his innovative spirit and dedication to advancing medical diagnostics. His patents serve as a testament to his expertise and impact in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile